S. Blanchet et al., BOTH RETINOIC ACID RECEPTORS ALPHA (RAR-ALPHA) AND GAMMA(RAR-GAMMA) ARE ABLE TO INITIATE MOUSE UPPER-LIP SKIN GLANDULAR METAPLASIA, Journal of investigative dermatology, 111(2), 1998, pp. 206-212
Embryonic mouse upper-lip skin explants treated with 16.7 mu M all-tra
ns retinoic acid (tRA) give rise to a glandular metaplasia of hair vib
rissa follicles; however, at this concentration, tRA can activate not
only the three retinoic acid receptors (RAR alpha, beta, and gamma), b
ut also the retinoid X receptors (RXR alpha, beta, and gamma) as a con
sequence of its isomerization to 9-cis retinoic acid. We therefore stu
died the respective roles of the RXR and RAR by treating RAR alpha(-/-
), beta(-/-), and gamma(-/-) skin explants with tRA and wildtype expla
nts with synthetic retinoids specific for RXR or for each of the RAR.
The null mutation of the RAR alpha, RAR beta, and RAR gamma genes did
not prevent tRA-induced hair glandular metaplasia, but RAR gamma inact
ivation dramatically reduced its ratio. As demonstrated by treating ex
plants with a RAR- or a RXR-specific panagonist (CD367 and Ro25-7386,
respectively), RAR are primarily responsible for this metaplasia. The
use of two retinoids (Ro40-6055, 8 x 10(-3) mu M, or CD437, 7.7 x 10(-
2) mu M) that are believed to act, respectively, as a RAR alpha- or a
RAR gamma-specific agonist showed that both these receptors can initia
te a metaplasia, In contrast, BMS453, a RAR beta-specific agonist, was
unable to give rise to any metaplasia, Nevertheless, the highest degr
ees and ratios of metaplasia were only obtained after treatment with t
he CD367 RAR panagonist, or with either Ro40-6055 or CD437 at a concen
tration sufficient to allow the activation of the three RAR, suggestin
g that RAR beta activation is required for a metaplasia of all vibriss
ae.